Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Cytometric cell-based assays for anti-striational antibodies in myasthenia gravis with myositis and/or myocarditis.

Kufukihara K, Watanabe Y, Inagaki T, Takamatsu K, Nakane S, Nakahara J, Ando Y, Suzuki S.

Sci Rep. 2019 Mar 27;9(1):5284. doi: 10.1038/s41598-019-41730-z.

2.

The Risks and Benefits of Immune Checkpoint Blockade in Anti-AChR Antibody-Seropositive Non-Small Cell Lung Cancer Patients.

Saruwatari K, Sato R, Nakane S, Sakata S, Takamatsu K, Jodai T, Mito R, Horio Y, Saeki S, Tomita Y, Sakagami T.

Cancers (Basel). 2019 Jan 24;11(2). pii: E140. doi: 10.3390/cancers11020140.

3.

CSF TACI and BAFF levels in patients with primary CNS lymphoma as novel diagnostic biomarkers.

Mizutani H, Nakane S, Ikeda T, Nakamura H, Takamatsu K, Makino K, Tawara N, Mukaino A, Watari M, Matsui H, Mukasa A, Ando Y.

Ann Clin Transl Neurol. 2018 Oct 19;5(12):1611-1616. doi: 10.1002/acn3.668. eCollection 2018 Dec.

4.

Immune checkpoint inhibitors in the onset of myasthenia gravis with hyperCKemia.

Takamatsu K, Nakane S, Suzuki S, Kosaka T, Fukushima S, Kimura T, Miyashita A, Mukaino A, Yamakawa S, Watanabe K, Jinnin M, Komohara Y, Ihn H, Ando Y.

Ann Clin Transl Neurol. 2018 Sep 23;5(11):1421-1427. doi: 10.1002/acn3.654. eCollection 2018 Nov.

5.

Autoimmune autonomic ganglionopathy: an update on diagnosis and treatment.

Nakane S, Mukaino A, Higuchi O, Watari M, Maeda Y, Yamakawa M, Nakahara K, Takamatsu K, Matsuo H, Ando Y.

Expert Rev Neurother. 2018 Dec;18(12):953-965. doi: 10.1080/14737175.2018.1540304. Epub 2018 Nov 1.

PMID:
30352532
6.

Trousseau's syndrome triggered by an immune checkpoint blockade in a non-small cell lung cancer patient.

Horio Y, Takamatsu K, Tamanoi D, Sato R, Saruwatari K, Ikeda T, Nakane S, Nakajima M, Saeki S, Ichiyasu H, Fujii K, Tomita Y.

Eur J Immunol. 2018 Oct;48(10):1764-1767. doi: 10.1002/eji.201847645. Epub 2018 Jul 19.

PMID:
29981156
7.

Autoimmune postural orthostatic tachycardia syndrome.

Watari M, Nakane S, Mukaino A, Nakajima M, Mori Y, Maeda Y, Masuda T, Takamatsu K, Kouzaki Y, Higuchi O, Matsuo H, Ando Y.

Ann Clin Transl Neurol. 2018 Feb 28;5(4):486-492. doi: 10.1002/acn3.524. eCollection 2018 Apr.

8.

Thomsen disease with ptosis and abnormal MR findings.

Mori Y, Yamashita S, Kato M, Masuda T, Takamatsu K, Kumamoto T, Sasaki R, Ando Y.

Neuromuscul Disord. 2016 Nov;26(11):805-808. doi: 10.1016/j.nmd.2016.08.016. Epub 2016 Sep 3.

PMID:
27666773
9.

Involvement of Macrophages in the Pathogenesis of Familial Amyloid Polyneuropathy and Efficacy of Human iPS Cell-Derived Macrophages in Its Treatment.

Suenaga G, Ikeda T, Komohara Y, Takamatsu K, Kakuma T, Tasaki M, Misumi Y, Ueda M, Ito T, Senju S, Ando Y.

PLoS One. 2016 Oct 3;11(10):e0163944. doi: 10.1371/journal.pone.0163944. eCollection 2016.

10.

Suppression of Th1-mediated autoimmunity by embryonic stem cell-derived dendritic cells.

Ikeda T, Hirata S, Takamatsu K, Haruta M, Tsukamoto H, Ito T, Uchino M, Ando Y, Nagafuchi S, Nishimura Y, Senju S.

PLoS One. 2014 Dec 18;9(12):e115198. doi: 10.1371/journal.pone.0115198. eCollection 2014.

11.

Degradation of amyloid beta by human induced pluripotent stem cell-derived macrophages expressing Neprilysin-2.

Takamatsu K, Ikeda T, Haruta M, Matsumura K, Ogi Y, Nakagata N, Uchino M, Ando Y, Nishimura Y, Senju S.

Stem Cell Res. 2014 Nov;13(3 Pt A):442-53. doi: 10.1016/j.scr.2014.10.001. Epub 2014 Oct 12.

12.

Therapy of peritoneally disseminated colon cancer by TAP-deficient embryonic stem cell-derived macrophages in allogeneic recipients.

Haga E, Endo Y, Haruta M, Koba C, Matsumura K, Takamatsu K, Ikeda T, Nishimura Y, Senju S.

J Immunol. 2014 Aug 15;193(4):2024-33. doi: 10.4049/jimmunol.1303473. Epub 2014 Jul 16.

13.

Application of iPS cell-derived macrophages to cancer therapy.

Senju S, Koba C, Haruta M, Matsunaga Y, Matsumura K, Haga E, Sasaki Y, Ikeda T, Takamatsu K, Nishimura Y.

Oncoimmunology. 2014 Jan 1;3(1):e27927. Epub 2014 Feb 14.

14.

Therapeutic effect of human iPS-cell-derived myeloid cells expressing IFN-β against peritoneally disseminated cancer in xenograft models.

Koba C, Haruta M, Matsunaga Y, Matsumura K, Haga E, Sasaki Y, Ikeda T, Takamatsu K, Nishimura Y, Senju S.

PLoS One. 2013 Jun 24;8(6):e67567. doi: 10.1371/journal.pone.0067567. Print 2013.

15.

Generation of a large number of functional dendritic cells from human monocytes expanded by forced expression of cMYC plus BMI1.

Haruta M, Tomita Y, Imamura Y, Matsumura K, Ikeda T, Takamatsu K, Nishimura Y, Senju S.

Hum Immunol. 2013 Oct;74(10):1400-8. doi: 10.1016/j.humimm.2013.05.017. Epub 2013 Jun 26.

PMID:
23811433
16.

Derlin-1 overexpression ameliorates mutant SOD1-induced endoplasmic reticulum stress by reducing mutant SOD1 accumulation.

Mori A, Yamashita S, Uchino K, Suga T, Ikeda T, Takamatsu K, Ishizaki M, Koide T, Kimura E, Mita S, Maeda Y, Hirano T, Uchino M.

Neurochem Int. 2011 Feb;58(3):344-53. doi: 10.1016/j.neuint.2010.12.010. Epub 2010 Dec 23.

PMID:
21185345

Supplemental Content

Loading ...
Support Center